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OBJECTIVES This study was designed to investigate the effects of cardiodepressant substances released from
postischemic myocardial tissue on myocardial calcium-regulating pathways.
BACKGROUND We have recently reported that new cardiodepressant substances are released from isolated
hearts during reperfusion after myocardial ischemia.
METHODS After 10 min of global ischemia, isolated rat hearts were reperfused, and the coronary effluent
was collected for 30 s. We tested the effects of the postischemic coronary effluent on cell
contraction, Ca21 transients and Ca21 currents of isolated rat cardiomyocytes by applying
fluorescence microscopy and the whole-cell, voltage-clamp technique. Changes in intracel-
lular phosphorylation mechanisms were studied by measuring tissue concentrations of cyclic
adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP), as well as
activities of cAMP-dependent protein kinase (cAMP-dPK) and protein kinase C (PKC).
RESULTS The postischemic coronary effluent, diluted with experimental buffer, caused a concentration-
dependent reduction of cell shortening and Ca21 transient in the field-stimulated isolated
cardiomyocytes of rats, as well as a reduction in peak L-type Ca21 current in voltage-clamped
cardiomyocytes. The current reduction resulted from reduced maximal conductance—not
from changes in voltage- and time-dependent gating of the L-type Ca21 channel. The
postischemic coronary effluent modified neither the tissue concentrations of cAMP or cGMP
nor the activities of cAMP-dPK and PKC. However, the effluent completely eliminated the
activation of glycogen phosphorylase after beta-adrenergic stimulation.
CONCLUSIONS Negative inotropic substances released from isolated postischemic hearts reduce Ca21
transient and cell contraction through cAMP-independent and cGMP-independent blockage
of L-type Ca21 channels. (J Am Coll Cardiol 2001;37:668–75) © 2001 by the American
College of Cardiology
We have recently reported that previously unknown and still
unidentified negative inotropic substances (NIS) are re-
leased from the postischemic myocardium (1,2). The
present study was performed to analyze the mechanism of
the negative inotropic effects mediated by NIS. We used
isolated rat cardiomyocytes as an in vitro bioassay system in
which the effects of postischemic coronary effluent from
isolated rat hearts were analyzed. In isolated ventricular
myocytes, contractility can be quantified by the extent and
rate of unloaded shortening (3). Because contractile activa-
tion is controlled by the Ca21 transient (i.e., by changes in
cytosolic Ca21 concentration [Ca21]c [4]), the effects of the
postischemic coronary effluent on cell shortening and Ca21
transient of isolated cardiomyocytes were studied together.
The Ca21 transient is primarily based on Ca21 release from
the sarcoplasmic reticulum triggered by Ca21 influx through
sarcolemmal L-type Ca21 channels (3–6). We therefore
conducted a separate group of experiments with whole-cell,
voltage-clamp experiments to test the effect of NIS on the
L-type Ca21 channel current, ICa. As phosphorylation
mechanisms are involved in L-type Ca21 channel regulation
(7,8), we conducted a further series of experiments to
address the question of whether NIS modulate Ca21 chan-
nel activity by changes in tissue concentrations of cyclic
adenosine monophosphate (cAMP) or cyclic guanosine
monophosphate (cGMP).
METHODS
Collection of coronary effluent from isolated rat hearts
after myocardial ischemia. Isolated rat hearts were per-
fused in the noncirculating mode at a constant flow
(10 ml/min) with a modified Krebs-Henseleit buffer
(KHB), as described elsewhere (1,2). The hearts were
subjected to 10 min of global stop-flow ischemia followed
by reperfusion. The postischemic coronary effluent was then
collected immediately at the onset of reperfusion, over a
period of 30 s. The coronary effluent from 20 postischemic
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hearts was pooled, and aliquots of the pooled solution were
stored at 270°C before testing. Postischemic pooled coro-
nary effluent was diluted with experimental buffer. In
addition, the coronary effluent of five control hearts, with no
previous ischemia, was collected and pooled by identical
techniques.
Isolation of ventricular myocytes. Adult isolated rat
hearts were perfused with oxygenated Ca21-free KHB
(37°C, pH 7.4) containing (in mmol/liter) 110 NaCl,
2.6 KCl, 1.2 KH2PO4, 1.2 MgSO4, 25 HEPES and 11
glucose. After 3 min, the hearts were perfused with KHB
containing 30 mmol/liter of Ca21 and collagenase type II
(355 U/ml). After 30 min of collagenase digestion, the
hearts were minced and incubated for another 15 min in the
same solution. The following washing steps increased
(Ca21)o incrementally, in steps of 200, 500 and 1000
mmol/liter. The cells were next layered over a 4% bovine
serum albumin (BSA) gradient and centrifuged for 1 min at
19 g; the resulting pellet was then resuspended in the
experimental buffer (in mmol/liter: 117 NaCl, 2.8 KCl, 0.6
MgCl2, 1.2 KH2PO4, 1.2 CaCl2, 20 glucose and 10
HEPES (pH 7.3). Typically, about 2 3 106 cells per rat
heart were obtained, 95% of which showed the typical
rod-shaped morphology with no blebs or granulation.
The cells were plated on four-well chamber glass slides
(Nunc, Naperville, Illinois), which had been coated with 10
mg/ml of laminin. After an attachment period of 30 min,
the buffer was exchanged for a staining solution containing
0.1% dimethyl sulfoxide (DMSO), 0.025% Pluronic F-127,
0.2% BSA and 5 mmol/liter of Fluo 3-AM. The cells were
incubated at room temperature for 45 min on an orbital
shaker, with oscillation of 40 rpm. After incubation, the
loading solution was replaced with fresh buffer, and the
incubation continued for 30 min.
Measurement of Ca21 transients and cell shortening.
The cells were superfused continuously with experimental
buffer at a flow rate of 2 ml/min and kept at room
temperature to minimize the cell leakage of fluorescent
probes (9). They were field-stimulated by a custom-built
stimulator through bipolar silver-chloride electrodes at a
frequency of 1 Hz for a duration of 5 ms. After a 2-min
equilibration period with 1-Hz stimulation, the coronary
effluent was superfused.
Cell shortening and Ca21-dependent changes in Fluo-3
fluorescence of single-ventricular myocytes were simulta-
neously measured by use of an Odyssey XL confocal laser
scan microscope (Noran Instruments, Middleton, Wiscon-
sin), using an argon ion laser with 6 mW of excitation at
488 nm. Emitted light was long-pass–filtered (.515 nm)
and collected at a frame rate of 120 images/s. Data were
stored on the hard disk of an Indy workstation (Silicon
Graphics, Mountain View, California). At an interval of
every 8 ms, Ca21 transients and cell length were determined
using a custom-written macro function for Object-Image
(10). Under control conditions, the rat ventricular myocytes
(n 5 36) shortened during stimulation by 7.3 6 0.4%
(mean 6 SEM). Changes in Ca21 transients are calculated
as peak systolic relative fluorescence units (rfu) minus
diastolic rfu without the calibration effort, owing to the
uncertain subcellular compartmentalization of the probes
(9). At baseline, Fluo-3 fluorescence increased from dia-
stolic 23.1 6 1.9 rfu to peak systolic 59.1 6 5.4 rfu.
Electrophysiology. Rat cardiomyocytes were isolated as
described previously (11,12) and superfused with saline
solution (37°C) containing (in mmol/liter) 150 NaCl,
5.4 KCl, 2 CaCl2, 1.2 MgCl2, 20 glucose and 5 HEPES,
with adjustment by NaOH to pH 7.4. For whole-cell,
patch-clamp experiments, borosilicate glass capillaries of
2 mm in diameter were pulled to the tips of ;2 mm in
diameter (1.5 to 2 MV resistance). Currents were recorded
with a RK300 input amplifier (Biologic, Echiroll, France),
filtered at 2 kHz and sampled at 5 kHz. Superimposed K1
currents were reduced by Cs1 electrode solution, as de-
scribed elsewhere (12). In the whole-cell mode of the
voltage clamp, 100- or 140-ms pulses to 0 mV were applied
at 1 Hz. The pulses started from a holding potential of 245
or 250 mV to inactivate the Na1 channel currents (3,12).
Experiments with seal resistance ,2 GV were discarded.
Membrane capacitance was measured by a train of 10 pulses
between 245 and 250 mV. The average membrane capac-
itance was 121 6 1.4 picofarad (pF) (58 cells). No data
correction took place for membrane leakage. The ICa was
expressed by current densities (picoampere [pA]/pF after
division by cell capacitance) to remove the variability of ICa
with cell size.
Effects of the coronary effluent on myocardial tissue
concentrations of cAMP and cGMP: activities of cAMP-
dPK, PKC and glycogen phosphorylase. Isolated rat
hearts were separately perfused at a constant flow
(10 ml/min), which was followed by serial perfusion, as
described elsewhere (1,2). At the onset of serial perfusion,
the coronary effluent of a donor heart (heart no. 1) was
reoxygenated and transported to a serially perfused second
heart (heart no. 2). Serial perfusion of the two hearts began:
1) after 30 min of separate perfusion at a constant flow or 2)
after 20 min of separate perfusion and 10 subsequent min of
global ischemia of heart no. 1.
Abbreviations and Acronyms
BSA 5 bovine serum albumin
cAMP 5 cyclic adenosine monophosphate
cAMP-d PK 5 cAMP-dependent protein kinase
cGMP 5 cyclic guanosine monophosphate
DMSO 5 dimethyl sulfoxide
KHB 5 Krebs-Henseleit buffer
NIS 5 negative inotropic substances
pA 5 picoampere
pF 5 picofarad
PKC 5 protein kinase C
pS 5 picosiemeus
rfu 5 relative fluorescence units
SR 5 sarcoplasmic reticulum
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Heart no. 2 was freeze-clamped 30 s after the onset of
serial perfusion for biochemical examination. Tissue levels
of cAMP were assayed according to Gilman (13), after
purification by column chromatography, as described else-
where (14). Cyclic GMP contents were analyzed by radio-
immunoassay, according to the technique of Harper et al.
(15). Cardiac cAMP-dPK activity was measured in the
particulate tissue fraction according to a modified method of
Murray et al. (16). Cyclic AMP-dPK activity was expressed
as the activity ratio of malantide phosphorylation in the
absence and presence of 2.8 mmol/liter of cAMP. Activity
of PKC was determined in the cytosolic and particulate
fractions, as described elsewhere (17,18), using the PKC kit
(BIOTRAK, Braunschweig, Germany). The activity of
glycogen phosphorylase b to a transformation (expressed as
percent total activity) was estimated according to the
method of England (19). Protein was measured as described
elsewhere (20), with use of ovalbumin as the standard agent.
Ethics. The investigation conforms to the “Position of the
American Heart Association on Research Animal Use,”
adopted by the Association in November 1984.
Statistical analysis. The results are expressed as the mean
value 6 SEM. For comparison of different groups, Kruskal-
Wallis analysis of variance was performed, followed by the
one-sided Mann-Whitney U test at p , 0.05. For compar-
ison of different values in the same group, the one-sided
Wilcoxon matched pairs test was performed at p , 0.05.
Adjustments of the post hoc test for multiple comparisons
(more than two groups) were carried out using a sequentially
rejective test procedure (Bonferroni-Holm).
Materials. Unless otherwise stated, substances were pur-
chased from Sigma Chemicals (Deisenhofen, Germany).
Collagenase type II was purchased from Worthington
(Freehold, New Jersey); BayK8644 from Bayer Pharmaceu-
tical (Leverkusen, Germany); and (32P)-g-ATP, (3H)-
cAMP, the (125J)-cGMP assay system and the PKC kit
BIOTRAK from Amersham-Buchler. BayK8644 and ni-
fedipine were prepared in DMSO, and aliquots were stored
at 220°C. Further dilutions were made in experimental
buffer.
RESULTS
Reduction of cell shortening and Ca21 transient. Figure
1 shows the original fast-time base recording of cell short-
ening and (Ca21)c fluorescence of a field-stimulated cardi-
omyocyte under control conditions and during superfusion
of postischemic coronary effluent, diluted to 1:4. The
effluent reduced the Ca21 transient and systolic cell short-
ening by 25% and 38%, respectively. The effect of the
effluent was reversible during superfusion with fresh exper-
imental buffer (washout).
Figure 2 shows the dependence of systolic cell shortening,
Ca21 transient and peak systolic Fluo-3 fluorescence on the
concentration of postischemic coronary effluent. At all
dilutions tested, a decrease in Ca21 transient and systolic
cell shortening reached steady-state within 1 min and was
reversible within 1 min on washout. The effects of the
effluent were evaluated once stable steady-state conditions
were reached. Increasing concentrations of postischemic
coronary effluent depressed cell contraction to a greater
extent than they did Ca21 transient. Diastolic Fluo-3
fluorescence did not change significantly. Superfusion of
undiluted nonischemic coronary effluent modified neither
cell contraction nor Ca21 transient (n 5 6; data not shown).
Signaling pathways. DEPRESSION OF THE CA21 CHANNEL
CURRENT, ICA. Figure 3A shows the net membrane current
of a rat ventricular myocyte produced by clamp-step depo-
larization from 245 to 0 mV for 100 ms. The K1 outward
currents were largely blocked by cell dialysis with Cs1 ions,
and Na1 inward current was inactivated by starting the
clamp step from the holding potential of 245 mV. The
resulting inward current can accordingly be attributed to
Figure 1. Fast time-base recording of changes in Fluo-3 fluorescence,
expressed as relative fluorescence units (rfu) and cell length (mm) of a single
field-stimulated rat cardiomyocyte under basal conditions (control), during
superfusion with postischemic coronary effluent (dilution 1:4) and during
superfusion with fresh experimental buffer (washout). Effluent 5 postisch-
emic coronary effluent.
Figure 2. Effects of pooled postischemic coronary effluent at different
dilutions on systolic cell shortening, Ca21 transient (peak systolic rfu 2
diastolic rfu) and peak systolic Fluo-3 fluorescence of isolated field-
stimulated rat cardiomyocytes. The effects were calculated as percent
changes compared with the values under basal conditions (control). The
data are presented as the mean value 6 SEM for six different myocytes
incubated with the indicated dilutions of postischemic effluent. Each
cardiomyocyte was used for only a single study employing one of five
different dilutions.
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L-type ICa (11). In Figure 3A, ICa peaks within 3 ms to
212.4 pA/pF and decays along a double-exponential time
course (thin-fitting lines in Fig. 3A [11]). The fast expo-
nential demonstrated a time constant of 4 ms; its amplitude
contributed to the peak current by 74%. The slow exponen-
tial had a time constant of 20 ms and contributed with an
amplitude of 26%. Superfusion of pooled postischemic
coronary effluent diluted by 1:4 reduced the peak ICa from
212.4 to 25.3 pA/pF (Fig. 3A). The effect became steady
within ;1 min. No change took place in the time to peak
current. It was possible to fit the decay of the effluent-
modified ICa to the same time constants of 4 and 20 ms and
to a very similar ratio of the amplitudes (78% and 22%,
respectively). These last results indicate that the kinetics of
the decay were insensitive to the effluent. Accordingly, we
conclude that the reduction of peak ICa by the postischemic
effluent is unlikely to be caused by changes in the activation
or inactivation variables. Nonischemic coronary effluent
collected from isolated control hearts did not modify the ICa
of the isolated cardiomyocytes (data not shown).
The voltage dependence of peak ICa (Fig. 3B) is typical
for currents through Ca21 channels of the L-type. The fit of
the corresponding current-voltage (iv) curves (according to
the Boltzman formula [3]) yielded the following gating
variables for the control currents: 212 mV for the potential
of half-maximal activation, 26.2 mV for the slope factor
and 48 mV for the reversal potential. Figure 3B indicates
that the effluent did not change these steady-state gating
variables. In the presence of the postischemic coronary
effluent diluted to 1:4, these variables yielded: 212 mV,
26.8 mV and 51 mV, respectively. However, it reduced the
whole-cell Ca21 conductance from 644 to 289 picosiemens
[pS]/pF, a decrease of 55%, as evaluated from the slope of
the iv curve.
The effect of the postischemic effluent on the Ca21
inward current was reversible on superfusion with experi-
mental buffer. Figure 4 shows the time course for the
development of this effect on peak ICa during superfusion
and washout of the postischemic effluent. The postischemic
coronary effluent diluted by 1:4 suppressed peak ICa within
1 min to a new steady-state value. During superfusion with
fresh experimental buffer (washout), the effect of the post-
ischemic coronary effluent on peak ICa was reversible within
1 min.
On a statistical basis, the pooled postischemic coronary
effluent significantly reduced the peak ICa in the cells tested.
In cells with complete iv curves, the potential of half-
maximal activation, the slope factor and the reversal poten-
tial were not significantly changed. The reduction of peak
ICa reached steady-state within 1 min. The time depen-
dence of the decay in ICa did not change significantly (p .
0.05). The paired comparison indicated a reduction of peak
ICa by 54%, from 211.8 6 0.7 to 25.4 6 0.4 pA/pF (n 5
9, p , 0.05) when the postischemic coronary effluent was
Figure 3. Reduction of whole-cell ICa by the postischemic coronary
effluent. A, ICa recorded from a rat ventricular myocyte before (control;
solid circles) and 1 min after adding 1:4 diluted postischemic effluent to
the superfusate (open circles). The time-dependent decay of ICa was
matched to a double-exponential function (thin solid line; time con-
stants 5 4 and 20 ms). B, Plot of peak ICa as a function of the test-step
potential (iv curve) before (control; filled circles) and after adding 1:4
diluted postischemic effluent to the superfusate (open circles). The holding
potential was 245 mV. Between 240 and 50 mV, voltage dependence of
peak ICa is matched, as calculated from the Boltzman formula. Effluent 5
postischemic coronary effluent (dilution 1:4).
Figure 4. Time course of the changes in peak ICa (filled circles), the
holding current at 250 mV (open squares) and the late current (current
measured at the end of the 100-ms pulse to 0 mV; filled triangles) during
superfusion with postischemic coronary effluent (dilution 1:4) and during
washout.
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diluted to 1:4, and by 80%, from 212.1 6 0.6 to 22.4 6
0.3 pA/pF (n 5 9, p , 0.05) when the dilution was 1:2.
Maximal Ca21 conductance was significantly reduced, by
56 6 2.7% (p , 0.05), during exposure to postischemic
coronary effluent (dilution 1:4). The slope conductance
between 260 and 100 mV was not significantly influenced
(31 6 3 pS/pF before and 25 6 2 pS/pF after addition of
postischemic coronary effluent) (p . 0.05). Likewise, the
holding current at 250 mV was not significantly changed by
the postischemic coronary effluent (Fig. 4). In only five of
nine cells, the inward currents between 260 and 2100 mV
tended to become more negative (as shown in Fig. 3B). On
a statistical basis, this effect was not significant. We attrib-
uted the minimal reduction of inward currents to a more
complete block of K1 currents by Cs1 when cell dialysis
increased the cytosolic Cs1 concentration with time.
Reduction of ICa by the postischemic coronary effluent
does not depend on prestimulation by isoproterenol or
BayK8644. We investigated whether the reduction of peak
ICa by the postischemic coronary effluent (dilution 1:4)
depended on the status of the Ca21 channel, as it may be
influenced by cAMP-dependent phosphorylation or by
Ca21 channel openers. Application of 30 nmol/liter of
isoproterenol (n 5 6) increased peak ICa from 212.6 6 1 to
219.5 6 1.2 pA/pF, and addition of the postischemic
coronary effluent reduced prestimulated peak ICa within
1 min to 210.5 6 1.2 pA/pF (i.e., by 54%) (p , 0.05).
Similarly, addition of 2 mmol/liter of 8-Br-cAMP (n 5 4)
increased peak ICa from 211.5 6 1.1 to 220.8 6 1.7
pA/pF, and the postischemic coronary effluent reduced ICa
to 210.3 6 1.6 pA/pF. Superfusion of 0.5 mmol/liter of
BayK8644 (n 5 5) increased peak ICa from 211.8 6 0.8 to
243.7 6 1.8 pA/pF, and the postischemic coronary effluent
reduced prestimulated peak ICa to 214.5 6 1.1 pA/pF (p ,
0.05). When peak ICa was reduced by superfusion of 0.1
mmol/liter of nifedipine to 24 6 0.6 pA/pF, addition of the
postischemic coronary effluent induced a further reduction
to 21.7 6 0.3 pA/pF (n 5 3). In summary, our results
indicate that the reducing effect of the postischemic coro-
nary effluent on the amplitude of peak ICa does not depend
on the status of the channel, as it is modified by cAMP-
dependent phosphorylation or by dihydropyridines.
Changes in tissue levels of cAMP and cGMP and
activities of cAMP-dPK and PKC. To establish whether
the observed effects of the postischemic coronary effluent are
modulated by an intracellular phosphorylation/
dephosphorylation mechanism of the L-type Ca21 channel,
we conducted serial perfusions of two isolated hearts. We
measured the tissue levels of cAMP and cGMP, as well as
the activity of cAMP-dPK in serially perfused heart no. 2.
As summarized in Table 1, the basal levels of cAMP and
cGMP in heart no. 2 were not significantly influenced by
the postischemic coronary effluent of heart no. 1, compared
with nonischemic effluent. The tissue level of cAMP in
heart no. 2 was elevated by isoproterenol stimulation (5
nmol/liter). We then investigated whether the postischemic
coronary effluent of heart no. 1 had an antiadrenergic effect
in heart no. 2 through cAMP-mediated signaling, com-
pared with nonischemic effluent. As shown in Table 1, there
were no significant differences between the two groups in
generation of cAMP or in the cAMP-dPK activity ratio.
The myocardial tissue level of cGMP did not increase
significantly in the presence of isoproterenol in the two
groups.
To preclude the possibility that signaling cascades other
than beta-adrenoceptor signaling may be involved in the
effects of the postischemic coronary effluent, we also mea-
sured the distribution of PKC activity in the cytosolic and
particulate fractions of the heart. As shown in Table 1, PKC
activity in heart no. 2 was not influenced by the postisch-
emic coronary effluent (Table 1).
Activity of glycogen phosphorylase. We studied activa-
tion of glycogen phosphorylase because this enzyme is
regulated by phosphorylase kinase, which in turn is activated
Table 1. Tissue Levels of Cyclic Adenosine Monophosphate and Cyclic Guanosine Monophosphate and Activities of Cyclic
Adenosine Monophosphate-Dependent Protein Kinase and of Protein Kinase C in Serially Perfused Heart No. 2: Effect of
Nonischemic and Postischemic Coronary Effluent of Heart No. 1











Nonischemic coronary effluent 2.89 6 0.23 0.21 6 0.02 0.21 6 0.01 940 6 46 149 6 22 13.7 6 2.1
(n 5 11) (n 5 7) (n 5 4) (n 5 6) (n 5 6) (n 5 6)
Postischemic coronary effluent 3.63 6 0.47 0.25 6 0.02 — 986 6 83 203 6 49 17.1 6 3.4
(n 5 5) (n 5 6) (n 5 5) (n 5 5) (n 5 5)
Isoproterenol, 5 mmol/liter‡
Nonischemic coronary effluent 6.19 6 0.95§ 0.21 6 0.05 0.29 6 0.02§ — — —
(n 5 5) (n 5 5) (n 5 5)
Postischemic coronary effluent 6.37 6 1.04§\ 0.23 6 0.05 0.30 6 0.03§ — — —
(n 5 5) (n 5 5) (n 5 5)
*Given as the quotient calculated from the activities obtained without adding and after adding cAMP. †Percent of total PKC activity. ‡Isoproterenol was infused to heart no.
2 at the onset of serial perfusion. §p , 0.05 vs. serial perfusion with nonischemic effluent in the absence of isoproterenol. \p , 0.05 vs. serial perfusion with postischemic effluent
in the absence of isoproterenol. Data presented as the mean value 6 SEM; number of hearts is given in parentheses.
cAMP 5 cyclic adenosine monophosphate; cGMP 5 cyclic guanosine monophosphate; cAMP-dPK 5 cAMP-dependent protein kinase; PKC 5 protein kinase C.
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by either cAMP-dPK or an increase in (Ca21)c (21–23).
The glycogen phosphorylase b to a transformation, mea-
sured in the presence of AMP, increased in heart no. 2 from
7.5 6 1.3% (controls, n 5 4) to 49.9 6 3.0% during
intracoronary infusion of 5 nmol/liter of isoproterenol (n 5
5) (p , 0.05). When serial perfusion was performed after
10 min of global ischemia of the first heart (n 5 5), the
activation of glycogen phosphorylase during exposure to
isoproterenol (5 nmol/liter) was reduced to 9.9 6 2.5% (p ,
0.05 vs. values during infusion of isoproterenol without
preceding ischemia of heart no. 1).
DISCUSSION
Negative inotropic substances released from isolated
postischemic hearts. The present study investigated the
mechanism by which NIS cause negative inotropic effects in
the isolated, field-stimulated ventricular myocytes of rats.
Our results indicate that the postischemic coronary effluent
contains NIS that decrease contractility (cell shortening) by
depression of Ca21 transient, rather than by Ca21 desensi-
tization. Furthermore, our results reveal that the sub-
stance(s) reduce Ca21 influx through L-type Ca21 chan-
nels. Accordingly, we postulate that this Ca21 channel
blockage is the initial event in the signaling cascade.
The chemical structure of NIS has remained unknown
until now. As evidenced by data that we have recently
reported, the substance(s) involved here are stable, heat-
resistant molecules that, most likely, are not proteins (1).
We have excluded the possibility that ionic imbalances,
lactic acid or pH shifts in the pooled coronary effluent of the
postischemic hearts contributed to its effects on contraction
and Ca21 transient of the isolated cardiomyocytes. The
substances(s) unidentified thus far are small molecules: the
pooled effluent was dialyzed against water (1:1000) by
means of a diaphragm with a pore size of 0.5 kd. The
remaining dialyzed solution— containing molecules
.0.5 kd—once lyophilized and dissolved in an appropriate
experimental buffer, did not influence cell shortening or Ca21
fluorescence of isolated cardiomyocytes. In contrast, when the
postischemic coronary effluent was filtered through a 0.5-kd
filter (YCO5 Amicon membrane, Millipore, Eschborn, Ger-
many), its effects on the calcium transients and cell shortening
were comparable to those of untreated postischemic coronary
effluent (data not shown).
Endogenous negative inotropic factors have been identi-
fied by other investigators using different experimental
procedures. Splanchnic hypoperfusion induces production
of a myocardial depressant factor in the splanchnic region
(24). Myocardial depressant factor is a low molecular weight
peptide that decreases myocardial contractile force. In ad-
dition, a cardiodepressant factor has been isolated by col-
umn chromatography from the plasma of dogs after
hypovolemic-traumatic shock (25). Further purification
yielded a hydrophilic peptide. Finally, several studies have
shown that endocardial and coronary vascular endothelium
modulate myocardial function (26–28). Endothelial cells
have been shown to release unidentified mediators that
upregulate or downregulate myocardial contractility (28). A
recent study has also disclosed the presence—in the super-
fusate of cultivated vascular and endocardial endothelial
cells—of an unidentified low molecular weight factor that
reduces myocardial contraction, predominantly by reducing
the myofilament response to calcium (29). In contrast, we
have recently provided evidence that the negative inotropic
mediators released from postischemic hearts are not derived
from endothelial cells (2).
Reduction of the L-type Ca21 current. The voltage-
clamp analysis described in the present study indicates that
NIS reduce the L-type Ca21 current ICa and intracellular
systolic Ca21 concentration, with the consequence of neg-
ative inotropy. In addition, a reduced intracellular Ca21
concentration causes metabolic effects, such as a decrease in
activation of glycogen phosphorylase. In contrast to our
data, Yang et al. (30) recently reported that the coronary
effluent of isolated hypoxic rat hearts contains unidentified
substances that depress contraction of isolated ventricular
myocytes, with only a minor reduction in intracellular Ca21
transient. Furthermore, hypoxic endothelial cells produce
diffusible factors that inhibit the myosin cross-bridge func-
tion (31). The apparent discrepancies between these reports
and our data are most likely due to different experimental
protocols. The cited reports describe superfusate of hypoxic
endothelial cells or coronary effluent from hypoxic hearts; in
our study, the isolated hearts were subjected to 10 min of
stop-flow ischemia, followed by reperfusion. We therefore
hypothesize that the substances, unidentified until now, that
are released during reperfusion and after ischemia are
different from those released during hypoxia.
The L-type Ca21 channel activity is known to be up-
regulated by cAMP and downregulated by cGMP-
dependent phosphorylation (7,8). The present results indi-
cate that the suppressing effect of NIS on ICa is not
modified by prestimulating the Ca21 channel activity
through cAMP-dependent phosphorylation (with either
isoproterenol or 8-Br-cAMP). Hence, modulation of the
cAMP-dPK pathway by NIS seems unlikely. This conclu-
sion is in accordance with our findings that the postischemic
coronary effluent did not modify cAMP tissue concentration
or cAMP-dPK activity in serially perfused isolated hearts.
Similarly, signaling through cGMP or PKC is unlikely,
because cGMP tissue levels and PKC activity were not
modulated by the effluent. Because the postischemic coro-
nary effluent blocked the ICa independently of the afore-
mentioned mechanisms that initiate Ca21 channel activa-
tion, it appears unlikely that dephosphorylation of subunits
of the L-type Ca21 channel is involved. We therefore
postulate that NIS interact with the Ca21 channel more
directly (i.e., by plugging the pore or by binding to the
channel protein) (32). Binding of NIS to the dihydropyri-
dine binding site of the channel protein is unlikely, because
suppression of ICa by the effluent was not modified when the
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cells were pretreated with the dihydropyridines BayK8644
or nifedipine. The mode of interaction between NIS and the
Ca21 channel remains to be elucidated by forthcoming
single-channel studies.
Potential pathophysiologic role of the negative inotropic
substances. In an attempt toward teleologic interpretation
of our findings, it may be considered whether the observed
reduction in Ca21 influx, Ca21 transient and cell shortening
could serve as an endogenous protection mechanism. In
terms of cardiac energy balance, the decrease in Ca21
transient and in contractility may reflect a salutary effect that
allows enhanced metabolic recovery of the cardiomyocytes
before full contractility is restored. Furthermore, the ques-
tion arises whether the effects of NIS interfere with the
phenomenon of “stunning” (33,34). The potential underly-
ing mechanisms of this postischemic contractile abnormal-
ity are the release of free radicals, cellular Ca21 overload and
decreased sensitivity of the contractile filaments to calcium
(reviewed in [35]). Overload of Ca21, in concert with
oxygen free radicals, may induce activation of Ca21-
dependent protease activity and consequent troponin I
proteolysis (36). Reduction in the L-type Ca21 current by
NIS may therefore represent a compensatory mechanism of
the myocardium, in the form of counteracting Ca21 over-
load during reperfusion. However, the apparent rapid re-
versibility of the negative inotropic effect during washout
may suggest that NIS play only a minor role in changes of
contractility of the postischemic myocardium. In contrast, it
may be possible that NIS are continuously released into the
microenvironment and retained by the postischemic myo-
cardial tissue. With its use of spillover from the mediators
into the coronary effluent, our experimental study may well
have failed to accurately ascertain the tissue concentrations
of NIS in the postischemic ventricle. These concentrations,
indeed, may be much higher (and may decrease over a
greater span of time) than those in the coronary effluent.
Conclusions. The present data confirm the release of NIS
during reperfusion of isolated hearts after ischemia. Our
findings indicate that these substance(s) or these mediator(s)
of yet unknown chemical structure reduce the L-type Ca21
current. Presumably, the Ca21 channel blockage is the first
step in a chain of cellular events leading to suppressed
cytosolic Ca21 transient and, in turn, to reduced contrac-
tions. Because the putative L-type Ca21 channel antagonis-
tic effect of NIS was not mediated by changes in cAMP or
cGMP levels, nor by changes in cAMP-dPK and PKC
activities, we postulate that there is a phosphorylation-
independent interaction between NIS and the Ca21 channel.
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